Inotiv (NOTV) Gains from Sales and Divestitures (2021 - 2022)
Inotiv (NOTV) reported Gains from Sales and Divestitures of $121000.0 for Q3 2022, up 505.0% on a YoY basis from $20000.0 in Q3 2021, and up 505.0% quarter-over-quarter from $20000.0 in Q3 2021.
Inotiv (NOTV) Gains from Sales and Divestitures (2021 - 2022) Analysis & Trends
Inotiv has reported Gains from Sales and Divestitures for 2 years, with the latest figure at $121000.0 in Q3 2022.
- For the quarter ending Q3 2022, Gains from Sales and Divestitures rose 505.0% year-over-year to $121000.0; the trailing twelve-month figure through Sep 2022 stood at $121000.0 (up 505.0% YoY), and the FY2022 full-year result was $121000.0, up 505.0% from the prior year.
- Gains from Sales and Divestitures for Q3 2022 stood at $121000.0, up from $20000.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $121000.0 in Q3 2022, with the low at $10.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Inotiv | 3.24 Mn | -11.94 Mn | 111.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 121,000.00 |
| Sep 30, 2022 | 121,000.00 |
| Sep 30, 2021 | 20,000.00 |
| Sep 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Mar 31, 2021 | 10.00 |
| Mar 31, 2021 | 10.00 |